Social Phobia
Conditions
Brief summary
Adults with Social Anxiety Disorder will be pseudo randomly assigned to either an individual cognitive behavior therapy, attention bias modification treatment (allocation ratio - 1.5:1). Outcome measures will be social anxiety symptoms and severity as measured by gold standard questionnaires as well as diagnosis of social anxiety disorder derived from structured clinical interviews based on Diagnostic and Statistical Manual (DSM) IV criteria. The investigators expect to find significant reduction in social anxiety symptoms in all of the groups, with the cognitive behavior therapy group showing greater reduction in symptoms than the other groups. Mechanisms of change in all of the groups will be examined via measures of cognitive biases, affect, and other common and specific factors.
Detailed description
120 Adults with Social Anxiety Disorder will be pseudo randomly assigned to either an individual cognitive behavior therapy (CBT), attention bias modification treatment (ABM)). Outcome measures will be social anxiety symptoms and severity as measured by gold standard questionnaires as well as diagnosis of social anxiety disorder derived from structured clinical interviews based on DSM-IV criteria. The investigators expect to find significant reduction in social anxiety symptoms in all of the groups, with the cognitive behavior therapy group showing greater reduction in symptoms than the other groups. Mechanisms of change in all of the groups will be examined via measures of cognitive biases, affect, and other common and specific factors.
Interventions
BEHAVIORALAttention Bias Modification (ABM)
Attention training via 8 weekly repeated trials of a dot-probe task intended to direct attention away from threat stimuli.
BEHAVIORALCognitive Behavior Therapy
CBT will consist of 16-20 weekly individual treatment sessions aimed to reduce symptoms via cognitive and behavioral interventions
Sponsors
Israel Science Foundation
Hebrew University of Jerusalem
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosis of Generalized Social Anxiety Disorder, LSAS\>50 * If on medication, patients must be on a stable dose * Hebrew language fluency
Exclusion criteria
* Primary Axis I or Axis II disorder other than SAD * suicidal ideation * Substance dependence within the past three months or current substance abuse * Mental retardation or another pervasive developmental disability * Current or past schizophrenia or psychosis, current bipolar disorder, or organic brain syndrome
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Liebovitz Social Anxiety Scale (LSAS) - diagnostic interview | Expected time frame of up to 32 weeks per participant. Participants will be assessed before and after the administration of the treatment, every 4 weeks during treatment and at 3 months follow-up | LSAS is a 24-items clinician-administered scale developed for the assessment of fear and avoidance associated with social situations. The LSAS assesses a wide range of both social interaction and performance/observation situations, which are rated for degree of fear/anxiety and frequency of avoidance. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Social Phobia Inventory (SPIN) - self-report questionnaire | Up to 32 weeks per participant. The SPIN will be administered before and after each treatment session and at 3 months follow-up | The SPIN is a widely used 17-item self-report questionnaire that assesses fear, avoidance and physiological symptoms of social anxiety. |
Countries
Israel
Outcome results
None listed